DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 50 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $231,000 | -51.2% | 80,368 | 0.0% | 0.00% | – |
| Q3 2016 | $473,000 | +96.3% | 80,368 | 0.0% | 0.00% | – |
| Q2 2016 | $241,000 | -76.0% | 80,368 | -57.2% | 0.00% | – |
| Q1 2016 | $1,006,000 | -55.6% | 187,680 | -1.6% | 0.00% | – |
| Q4 2015 | $2,265,000 | +62.8% | 190,823 | +12.6% | 0.00% | – |
| Q3 2015 | $1,391,000 | +0.5% | 169,429 | +70.8% | 0.00% | – |
| Q2 2015 | $1,384,000 | +75.2% | 99,222 | +201.6% | 0.00% | – |
| Q1 2015 | $790,000 | +58.0% | 32,896 | +8.3% | 0.00% | – |
| Q4 2014 | $500,000 | +29.5% | 30,373 | +0.1% | 0.00% | – |
| Q3 2014 | $386,000 | -70.2% | 30,355 | -47.1% | 0.00% | – |
| Q2 2014 | $1,295,000 | -23.0% | 57,369 | -3.7% | 0.00% | – |
| Q1 2014 | $1,682,000 | – | 59,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |